SciELO - Scientific Electronic Library Online

 
vol.52 número3Factores de insatisfacción al alta de un servicio de Clínica Médica del ParaguayProducción de Biogás a partir de residuos orgánicos generados en el Hospital de Clínicas: Un estudio preliminar índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

  • No hay articulos citadosCitado por SciELO

Links relacionados

  • No hay articulos similaresSimilares en SciELO

Compartir


Anales de la Facultad de Ciencias Médicas (Asunción)

versión impresa ISSN 1816-8949

Resumen

GONZALEZ, Silvia Adriana et al. Epilepsy and Variables. Department of Neurology, Hospital de Clínicas from 2016 to 2018. An. Fac. Cienc. Méd. (Asunción) [online]. 2019, vol.52, n.3, pp.47-52. ISSN 1816-8949.  https://doi.org/10.18004/anales/2019.052.03.47-052.

In the world there are about 50 million people with epilepsy. In low and middle income countries they suggest a much higher proportion, between 7 and 14 per 1000 people. Poor populations and those living in vulnerable situations, particularly in low and middle income countries, carry a disproportionately high burden; which poses a threat to public health and economic and social development. 1 Whereby the purpose of the study was to know the epidemiological characteristic of this population. Were analyzed 281 records of patients with epilepsy, over a period of two years, between 16 and 91 years. Results: 51.9% correspond to the male sex and 48.1% to the female. 63.34% presented focal crisis. 59.2 of epilepsy cases are accompanied by psychiatric disorders. Only 5% have claimed to have suffered any adverse effect to the medication. The cause of epilepsy in 58.58% is unknown. Within the causes of secondary epilepsy; Stroke is 22.4%. Notably, the 30.2% of patients do not have a brain imaging study; 41.93% presented a crisis with treatment, but 50% of patients performed irregular treatment. 53.73% had treatment with a single anticonvulsant drug, with Carbamazepine being the most used. Conclusion: Epilepsy has a high prevalence within neurological disorders. It affects the male sex more importantly, with the focal crisis being the most frequent. The low association with psychiatric disorders found; it forces us to emphasize being more exhaustive in the search for these. The cause is unknown in a high percentage. The most frequent causes of secondary epilepsy were CVA and Skull Trauma. A considerable percentage continue with crisis due to non-compliance with treatment. Carbamazepine, Valproic Acid and Phenytoin are the most used, due to their costs and accessibility, efforts should be established to propose intervention strategies, to facilitate the monitoring of patients and so that they can also benefit from new anticonvulsant drugs.

Palabras clave : epilepsy; population at risk; antiepileptic drugs..

        · resumen en Español     · texto en Español     · Español ( pdf )